Free Confidential Lawsuit Evaluation: If you or a loved one was injured by the side effects of Avelox, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Avelox and we can help.
Update: Fluoroquinolone MDL Moving Forward in Minnesota
March 22, 2017 – Product liability lawsuits alleging peripheral neuropathy from Levaquin, Cipro and Avelox are moving forward in the U.S. District Court for the District of Minnesota, with at least 10 bellwether cases being prepped for trial. Per a recent update, there are at least 738 lawsuits pending in the fluoroquinolone multidistrict litigation (MDL No. 2642), most of which involve Levaquin.
What is Avelox?
Avelox is a fluoroquinolone antibiotic medication that is promoted as a first-line therapy for the treatment of common bronchitis, sinusitis infections and acquired pneumonia. The drug is available in tablet form and as an intravenous (IV) injection, which is for use in a hospital setting only. Avelox is manufactured by Bayer Healthcare Pharmaceuticals, Inc. and marketed by Merck, and was approved by the U.S. Food & Drug Administration (FDA) in December 1999.
FDA Black Box Warning
In October 2008, the FDA required Bayer to include a Black Box Warning – the strictest such warning allowed by law – on the labeling of Avelox to inform the public of the potential side effects the drug may cause. According to the agency, Avelox may cause liver damage, muscle injuries and ruptures of the tendons, the tissues that bind muscles together. Avelox has also been linked to the life-threatening skin disease Stevens-Johnson Syndrome (SJS).
Avelox and Peripheral Neuropathy
In August 2013, the FDA issued a Drug Safety Communication advising the public that Avelox and other antibacterial medications belonging to the fluoroquinolone class would have their labeling updated in order to “better describe the serious side effect of peripheral neuropathy,” a severe and potentially irreversible form of nerve damage. Neuropathy can occur soon after Avelox treatment begins, in some cases less than one week. This side effect has been linked to oral and injectable fluoroquinolones, but not to topical formulations that are applied to the eyes and ears.
- Change in sensation to light touch, pain, or temperature
- Change in sense of body position
- Loss of reflexes
- Muscle wasting
Avelox Lawsuit Filed in Pennsylvania
June 27, 2016 – An Arkansas man who claims he was permanently injured after taking Avelox and Levaquin (generic: levofloxacin) has filed a lawsuit against Bayer, Merck, Johnson & Johnson and Janssen Pharmaceuticals. Plaintiff John Reed alleges that in 2008 he suffered serious side effects including irreversible peripheral neuropathy from Avelox and Levaquin. Reed holds the defendants responsible because they allegedly failed to provide adequate warnings on the drugs, resulting in him sustaining physical injuries which required medical treatment and monitoring. The complaint was filed May 27 in the U.S. District Court for the Eastern District of Pennsylvania under case number 2:16-cv-02615-GAM.
Fluoroquinolone Antibiotics Should Only be Used as Last Resort, FDA Warns
May 12, 2016 – Avelox and other fluoroquinolone antibiotics should only be used as a last resort to treat patients with sinusitis, bronchitis and uncomplicated urinary tract infections (UTIs), according to an FDA warning issued today. The agency said the “serious side effects associated with fluoroquinolones generally outweigh the benefits” for patients with these conditions. Fluoroquinolones should only be prescribed to patients without other treatment options, according to the FDA.
About Avelox Class Action Lawsuits
Although we are a nationally recognized class action firm, the Products Liability Litigation Group at our law firm has decided against the filing of a Avelox Class Action Suit, and is currently filing individual claims on behalf of individuals and/or their family members who have been injured after taking Avelox.
A class action is a type of lawsuit filed with the court on behalf of large group of people or “class” of individuals that have been injured or wronged. The class is represented by the law firm and the case is generally decided upon a single member of the class who is sometimes referred to as the “class representative or class rep.”
Why Our Law Firm Is Filing Individual Lawsuits Opposed To a Class Action
In some instances, a class action may offer some advantages, as they aggregate a large number of individualized claims into one representational lawsuit. The aggregation can increase the efficiency of the legal process, lower the costs of litigation and in some cases offer the solution to a common problem wherein small recoveries do not provide the incentive for any individual or law firm to file an individual lawsuit.
However, a class action suit can also be a detriment to many class members, as they are often forced into a blanket “low ball settlement” and higher attorney fees. At Schmidt & Clark, LLP we understand that our clients are suffering emotionally and economically due to loss of wages and/or high medical bills and we plan to maximize each client’s recovery by filing individual Avelox Lawsuits on their behalf.
Do I Have an Avelox Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Avelox Lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Free Confidential Case Evaluation: Again, if you or a loved one has been injured by Avelox side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.